Aussie Scientist Warns Seasonal Flu Could Be Cause Of Pediatric Fits
This article was originally published in PharmAsia News
An Australian Nobel Prize-winning scientist warns a recalled seasonal flu vaccine could be the cause of a nine-fold increase in febrile fits among young children
You may also be interested in...
Shanghai Henlius Biotech has begun dosing in a Phase I trial for its HLX14 planned biosimilar version of denosumab. Multiple biosimilar developers are vying to take a slice of the market for rivals to Amgen’s Xgeva/Prolia original.
After issuing Form 483 observations, the FDA has issued a warning letter to Aurobindo’s AuroLife linked to its manufacturing facility in New Jersey. The agency has warned that if the violations are not corrected promptly, it will take further action to ensure quality control.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by the European pharmaceutical industry federation EFPIA. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.